Belpointe Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.27M | Sell |
6,447
-334
| -5% | -$119K | 0.08% | 217 |
|
|
2025
Q4 | $2.22M | Buy |
6,781
+390
| +6% | +$124K | 0.08% | 205 |
|
|
2025
Q3 | $1.8M | Sell |
6,391
-173
| -3% | -$50.2K | 0.07% | 244 |
|
|
2025
Q2 | $1.83M | Buy |
6,564
+165
| +3% | +$46.7K | 0.08% | 216 |
|
|
2025
Q1 | $1.99M | Sell |
6,399
-3,361
| -34% | -$992K | 0.1% | 178 |
|
|
2024
Q4 | $3.26M | Buy |
9,760
+1,638
| +20% | +$486K | 0.2% | 104 |
|
|
2024
Q3 | $2.62M | Buy |
8,122
+1,846
| +29% | +$604K | 0.16% | 128 |
|
|
2024
Q2 | $1.96M | Sell |
6,276
-422
| -6% | -$124K | 0.14% | 146 |
|
|
2024
Q1 | $1.9M | Sell |
6,698
-1,005
| -13% | -$294K | 0.14% | 134 |
|
|
2023
Q4 | $2.22M | Sell |
7,703
-1,477
| -16% | -$402K | 0.19% | 100 |
|
|
2023
Q3 | $2.47M | Buy |
9,180
+1,644
| +22% | +$410K | 0.26% | 72 |
|
|
2023
Q2 | $1.67M | Sell |
7,536
-1,724
| -19% | -$400K | 0.18% | 115 |
|
|
2023
Q1 | $2.24M | Buy |
9,260
+3,034
| +49% | +$745K | 0.12% | 175 |
|
|
2022
Q4 | $1.64M | Buy |
6,226
+256
| +4% | +$68.6K | 0.1% | 204 |
|
|
2022
Q3 | $1.34M | Buy |
5,970
+706
| +13% | +$171K | 0.09% | 235 |
|
|
2022
Q2 | $1.28M | Sell |
5,264
-806
| -13% | -$198K | 0.09% | 244 |
|
|
2022
Q1 | $1.47M | Buy |
6,070
+638
| +12% | +$147K | 0.09% | 242 |
|
|
2021
Q4 | $1.22M | Buy |
5,432
+578
| +12% | +$122K | 0.08% | 263 |
|
|
2021
Q3 | $1.03M | Sell |
4,854
-717
| -13% | -$165K | 0.07% | 303 |
|
|
2021
Q2 | $1.36M | Buy |
5,571
+1,278
| +30% | +$314K | 0.1% | 226 |
|
|
2021
Q1 | $1.07M | Sell |
4,293
-1,524
| -26% | -$364K | 0.09% | 239 |
|
|
2020
Q4 | $1.34M | Buy |
5,817
+844
| +17% | +$195K | 0.12% | 192 |
|
|
2020
Q3 | $1.26M | Sell |
4,973
-201
| -4% | -$49.8K | 0.14% | 161 |
|
|
2020
Q2 | $1.22M | Sell |
5,174
-400
| -7% | -$91.3K | 0.16% | 134 |
|
|
2020
Q1 | $1.13M | Sell |
5,574
-2,105
| -27% | -$460K | 0.2% | 116 |
|
|
2019
Q4 | $1.85M | Buy |
7,679
+3,079
| +67% | +$679K | 0.24% | 103 |
|
|
2019
Q3 | $890K | Buy |
4,600
+450
| +11% | +$86.4K | 0.14% | 160 |
|
|
2019
Q2 | $765K | Sell |
4,150
-2,796
| -40% | -$501K | 0.15% | 145 |
|
|
2019
Q1 | $1.32M | Buy |
6,946
+1,096
| +19% | +$209K | 0.26% | 63 |
|
|
2018
Q4 | $1.14M | Buy |
5,850
+2,541
| +77% | +$496K | 0.29% | 71 |
|
|
2018
Q3 | $686K | Buy |
3,309
+1,212
| +58% | +$239K | 0.11% | 189 |
|
|
2018
Q2 | $387K | Sell |
2,097
-746
| -26% | -$132K | 0.11% | 218 |
|
|
2018
Q1 | $485K | Buy |
2,843
+441
| +18% | +$81K | 0.14% | 169 |
|
|
2017
Q4 | $418K | Sell |
2,402
-101
| -4% | -$17.9K | 0.09% | 269 |
|
|
2017
Q3 | $467K | Buy |
+2,503
| New | +$443K | 0.11% | 203 |
|
Other funds holding AMGN
VCM
VPM
Belpointe Asset Management's AMGN Position: Q1 2026 in Review
Belpointe Asset Management reduced its Amgen (AMGN) stake by 4.9% in Q1 2026, selling an estimated $119K and leaving 6,447 shares worth $2.27M. The position accounts for 0.08% of the portfolio, ranked #217.
Belpointe Asset Management first reported a position in AMGN in Q3 2017 and has held it in 35 quarters since. The position peaked at $3.26M in Q4 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Belpointe Asset Management held 6,447 shares of Amgen worth $2.27M as of Q1 2026.
- Belpointe Asset Management sold 334 Amgen shares in Q1 2026, an estimated $119K.
- Amgen made up 0.08% of Belpointe Asset Management's portfolio in Q1 2026, its #217 holding.
- Belpointe Asset Management first reported a position in Amgen in Q3 2017 and has held it in 35 quarters since.
- Belpointe Asset Management's Amgen position peaked at $3.26M in Q4 2024.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.